Mesenchymal stromal cells and fibroblasts: A case of mistaken identity?

Cytotherapy

Volumn 14, Issue 5, 2012, Pages 516-521

  Hematti, Peiman ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; COLLAGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DIPEPTIDYL PEPTIDASE IV; ENDOGLIN; GAMMA INTERFERON; PROSTAGLANDIN E2; VASCULAR CELL ADHESION MOLECULE 1;

ACHILLES TENDINITIS; ADIPOSE TISSUE; BONE CELL; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CARTILAGE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL STRUCTURE; CYTOKINE RELEASE; CYTOSKELETON; EXTRACELLULAR MATRIX; FIBROBLAST; GRAFT VERSUS HOST REACTION; HEART INFARCTION; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MESENCHYMAL STROMA CELL; POLYMORPHONUCLEAR CELL; PREPUCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATION; REVIEW; SKIN FIBROBLAST; STRUCTURE ANALYSIS; TREATMENT INDICATION; TREATMENT RESPONSE; WOUND HEALING;

EID: 84859777008     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.677822     Document Type: Article

References (66)

1. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper- Cortenbach I, Marini FC, et al. Clarifi cation of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393-5.
2. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230-47.
3. Friedenstein AJ, Piatetzky S II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16:381-90.
4. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fi broblast colonies in monolayer cultures of guineapig bone marrow and spleen cells. Cell Tissue Kin. 1970;3: 393-403.
5. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17: 331-40.
6. Friedenstein AJ. Marrow stromal fi broblasts. Calcif Tissue Int. 1995;56(Suppl 1):S17.
7. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defi ning multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7.
8. Owen M, Friedenstein AJ. Stromal stem cells: marrowderived osteogenic precursors. Ciba Found Symp. 1988;136: 42-60.
9. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9: 641-50.
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-7.
11. Bianco P, Kuznetsov SA, Riminucci M, Fisher LW, Spiegel AM, Robey PG. Reproduction of human fi brous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J Clin Invest. 1998;101:1737-44.
12. Simmons PJ, Torok-Storb B. Identifi cation of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991;78:55-62.
13. Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest. 2000;105:1663-8.
14. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2:313-9.
15. Bianco P, Robey PG, Saggio I, Riminucci M. âMesenchymal' stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and signifi cance in incurable skeletal disease. Human Gene Ther. 2010;21:1057-66.
16. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identifi cation of mesenchymal stem/progenitor cells in human fi rst-trimester fetal blood, liver, and bone marrow. Blood. 2001;98:2396-402.
17. Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal stromal cells. Ann NY Acad Sci. 2009;1176:101-17.
18. Sabatini F, Petecchia L, Tavian M, Jodon de Villeroche V, Rossi GA, Brouty-Boye D. Human bronchial fi broblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest J Tech Meth Pathol. 2005;85:962-71.
19. L orenz K, Sicker M, Schmelzer E, Rupf T, Salvetter J, Schulz- Siegmund M, et al. Multilineage differentiation potential of human dermal skin-derived fi broblasts. Exp Dermatol. 2008;17:925-32.
20. + perivascular cells and fi broblasts. Exp Hematol. 2008;36:642-54.
21. Lysy PA, Smets F, Sibille C, Najimi M, Sokal EM. Human skin fi broblasts: from mesodermal to hepatocyte-like differentiation. Hepatology. 2007;46:1574-85.
22. Blasi A, Martino C, Balducci L, Saldarelli M, Soleti A, Navone SE, et al. Dermal fi broblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-infl ammatory and angiogenic potential. Vasc Cell. 2011;3:5.
23. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, et al. Characterization of human bone marrow fi broblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56:289-301.
24. Hanson SE, Kim J, Johnson BH, Bradley B, Breunig MJ, Hematti P, et al. Characterization of mesenchymal stem cells from human vocal fold fi broblasts. Laryngoscope. 2010;120: 546-51.
25. Cappellesso-Fleury S, Puissant-Lubrano B, Apoil PA, Titeux M, Winterton P, Casteilla L, et al. Human fi broblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol. 2010;30:607-19.
26. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33:1402-16.
27. Trivedi P, Hematti P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol. 2008;36:350-9.
28. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC. SSEA-4 identifi es mesenchymal stem cells from bone marrow. Blood. 2007;109:1743-51.
29. Wagner W, Ho AD. Mesenchymal stem cell preparations: comparing apples and oranges. Stem Cell Rev. 2007;3: 239-48.
30. Ho AD, Wagner W, Franke W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy. 2008;10:320-30.
31. Samuelsson H, Ringden O, Lonnies H, Le Blanc K. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells. Cytotherapy. 2009;11: 129-36.
32. Schellenberg A, Stiehl T, Horn P, Joussen S, Pallua N, Ho AD, Wagner W. Population dynamics of mesenchymal stromal cells during culture expansion. Cytotherapy. 2012;14: 401-11.
33. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, et al. Diversity, topographic differentiation, and positional memory in human fi broblasts. Proc Natl Acad Sci USA. 2002;99:12877-82.
34. Graf T. Historical origins of transdifferentiation and reprogramming. Cell Stem Cell. 2011;9:504-16.
35. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fi broblast cultures by defi ned factors. Cell. 2006;126:663-76.
36. Lushaj EB, Anstadt E, Haworth R, Roenneburg D, Kim J, Hematti P, et al. Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro. Cytotherapy. 2011;13:400-6.
37. Friedenstein AJ, Lalykina KS. Thymus cells are inducible to osteogenesis. Eur J Immunol. 1972;2:602-3.
38. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499-506.
39. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol. 2009;37:1445-53.
40. Prockop DJ. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther. 2009;17:939-46.
41. Phinney DG, Prockop DJ. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair. Current views. Stem Cells. 2007;25:2896-902.
42. Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefi t? Cytotherapy. 2008; 10:771-4.
43. Haniffa MA, Collin MP, Buckley CD, Dazzi F. Mesenchymal stem cells: the fi broblasts ' new clothes? Haematologica. 2009;94:258-63.
44. Jones S, Horwood N, Cope A, Dazzi F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol. 2007;179:2824-31.
45. Donnelly JJ, Xi MS, Rockey JH. A soluble product of human corneal fi broblasts inhibits lymphocyte activation. Enhancement by interferon-gamma. Exp Eye Res. 1993;56:157 -65.
46. Le JM, Vilcek J. Accessory function of human fi broblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. J Immunol. 1987;139:3330-7.
47. Shimabukuro Y, Murakami S, Okada H. Interferon-gammadependent immunosuppressive effects of human gingival fi broblasts. Immunology. 1992;76:344-7.
48. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24:386-98.
49. Theobald VA, Lauer JD, Kaplan FA, Baker KB, Rosenberg M. âNeutral allografts ' : lack of allogeneic stimulation by cultured human cells expressing MHC class I and class II antigens. Transplantation. 1993;55:128-33.
50. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31:890-6.
51. Korn JH. Modulation of lymphocyte mitogen responses by cocultured fi broblasts. Cell Immunol. 1981;63:374-84.
52. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of infl ammation. Mol Ther J Am Soc Gene Ther. 2012;20:14-20.
53. Brockes JP, Kumar A, Velloso CP. Regeneration as an evolutionary variable. J Anatomy. 2001;199:3-11.
54. Bayat A, McGrouther DA, Ferguson MW. Skin scarring. Br Med J. 2003;326:88-92.
55. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fi brosis. Int Rev Cytol. 2007;257:143-79.
56. Eming SA, Krieg T, Davidson JM. Infl ammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127:514-25.
57. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol. 1975;78:71-100.
58. Weng JY, Du X, Geng SX, Peng YW, Wang Z, Lu ZS, et al. Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant. 2010;45:1732-40.
59. Tolar J, Le Blanc K, Keating A, Blazar BR. Concise review. Hitting the right spot with mesenchymal stromal cells. Stem Cells. 2010;28:1446-55.
60. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 1995;16:557-64.
61. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307-16.
62. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-13.
63. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus- host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439-41.
64. Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009;11:503-15.
65. Chhetri DK, Berke GS. Injection of cultured autologous fi broblasts for human vocal fold scars. Laryngoscope. 2011;121:785-92.
66. Obaid H, Clarke A, Rosenfeld P, Leach C, Connell D. Skinderived fi broblasts for the treatment of refractory achilles tendinosis: preliminary short-term results. J Bone Joint Surg Am. 2012;94:193-200.